Private medical cannabis prescriptions in the UK: what the evidence suggests and what patients need to know
A calm look at how private providers dominate medical cannabis prescribing in the UK, the trade‑offs, and a practical step to take this week.
Background
In 2018 the government altered the Misuse of Drugs Regulations, allowing both the NHS and private clinicians to prescribe cannabis‑based medicinal products (CBMPs). The change matters because it opened a legal market for a therapy that had previously been available only through unlicensed channels. According to Health, the NHS now limits prescriptions to a narrow set of conditions – most notably rare, severe forms of epilepsy in children and adults, and muscle stiffness or spasms caused by multiple sclerosis (MS). The same source notes that the vast majority of prescriptions for medical cannabis are being issued through private healthcare.
How cannabis‑based medicines work
CBMPs contain cannabinoids, the active compounds that interact with the body’s endocannabinoid system – a network of receptors that modulate pain, muscle tone, inflammation and mood. The two best‑studied cannabinoids are tetrahydrocannabinol (THC), which produces psychoactive effects, and cannabidiol (CBD), which lacks intoxication but can influence pain pathways and inflammation. When a clinician prescribes a CBMP, the goal is usually to harness one or both of these actions to relieve symptoms that have not responded to conventional drugs.
NHS versus private provision
| Aspect | NHS prescribing | Private provider prescribing |
|---|---|---|
| Typical conditions covered | Rare severe epilepsy, MS‑related spasticity | Wider range – chronic pain, anxiety, insomnia, other neurological or musculoskeletal conditions |
| Access route | Referral from GP, specialist review, strict eligibility criteria | Direct consultation with private clinic, often after self‑referral or GP referral that did not result in an NHS prescription |
| Cost to patient | No charge (prescribed within NHS budget) | Paid out‑of‑pocket; price varies by clinic and product formulation |
| Waiting time | Can be several months due to specialist bottlenecks | Usually weeks, depending on clinic capacity |
| Regulatory oversight | NHS formulary and NHS England clinical commissioning policies | Private clinics must hold a licence to prescribe CBMPs, but pricing and follow‑up are not standardised |
The trade‑off here is clear: NHS access is free but tightly limited; private routes are faster and cover more conditions, but they shift the financial burden onto the patient.
Who gains and who loses?
Patients with qualifying epilepsy or MS who can navigate the NHS pathway gain a prescription at no personal cost. However, most people seeking cannabis for chronic pain, anxiety or sleep disorders fall outside the NHS remit and therefore must turn to private clinics.
Private clinics benefit from higher fees and the ability to market a broader catalogue of products. The system also creates a two‑tier situation: wealthier patients can obtain the treatment quickly, while those on lower incomes may be forced to either wait for NHS approval (which may never come) or go without.
What the source leaves open
The call for public responses does not reveal how many private prescriptions are actually being written, nor does it detail the average price patients pay. It also does not discuss clinical outcomes – whether private patients experience measurable symptom relief, or if adverse effects are being monitored with the same rigour as NHS patients. Without that data, the claim that the vast majority are private remains a statement of volume, not of quality or safety.
A practical step for this week
If you are considering medical cannabis, start by asking your NHS GP whether your condition meets the current NHS criteria. A documented referral can later support a private consultation and may give you leverage to negotiate price or seek a second opinion. Even if the NHS route is unavailable, having a clear record of your symptoms and any previous treatments will help private clinicians assess you more objectively.
